Knowledge Bowl at #ACR21 ⭐️In a suspected PAN case, you order a peripheral smear to look for this potential etiology, ➡️Hairy cells @RheumNow

Knowledge Bowl at #ACR21 ⭐️Increased susceptibility to a certain most common adult vasculitis is conferred by this HLA allele ➡️HLA DRB10404 @RheumNow

#ACR21 Knowledge Bowl Final Question: Vasculitis Mimics: @RheumNow https://t.co/laD3oO8Uq9

Knowledge Bowl at #ACR21 ⭐️This HLA allele can be seen in a certain vasculitis where panuveitis is a possibility and has a venulitis predilection ➡️HLA B51 @RheumNow

One of the most provocative & interesting abstracts the GCA space at #ACR21 -so many sides to consider- I will be discussing at @RheumNow Panel w @drdavidliew WEDS AM @AdamJBrownMD @CCalabreseDO @CleClinicMD #vasculitis @EBRheum @anisha_dua https://t.co/STR9gNPdsO

• KenWarringtonMD on Twitter: "#ACR21
Baricitinib for relapsing #GCA &#1…

TCZ in GCA: one disadvantage is that you can't use CRP+/- ESR for flares Mavrilimumab in GCA: - CRP/ESR consistently go up with symptomatic flares - CRP/ESR up less (cf. placebo), in the absence of Sx flares More signal, less noise. phase 2 post-hoc #ACR21 ABST1401 @RheumNow https://t.co/c0lMJMcQv0

Baricitinib for *relapsing* GCA (Th1+Th17) w abbreviated steroid wean (15-22w) Despite being tougher to treat: 100% off steroids at 24w 93% off steroids at 52w no ischemic Sx promising as another GCA Rx option! (post-cessation 4pts flared) @MayoClinic #ACR21 ABST1396 @RheumNow https://t.co/dqFnHQYogk

"GCA is not a single, monolithic disease" - Christian Dejaco, rightfully asking why we don't stratify treatment/trials in GCA #ACR21 PMR/GCA Study Group @RheumNow @Sarah_L_Mackie @profbdasgupta @EBRheum @RichardPAConway @SattuiSEMD @drceowen